Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1307.0000 -67.20 (-4.89%)
NSE Jul 03, 2026 15:31 PM
Volume: 326.2K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1307.00
-4.89%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research has gained 169.48% in the last 1 Year
More from Rubicon Research Ltd.
Recommended
Five Interesting Stocks Today - July 3, 2026
The Baseline | 03 Jul 2026, 05:37PM
Market closes higher, led by IT and realty stocks
Trendlyne Marketwatch | 03 Jul 2026, 03:53PM
Q1FY27: What's driving the strongest growth forecasts?
The Baseline | 02 Jul 2026, 02:42PM